CNR Institutional Research Information System

POGGI, ELVIRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.997
EU - Europa 1.507
NA - Nord America 1.466
SA - Sud America 307
AF - Africa 43
OC - Oceania 2
Totale 5.322
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.372
IT - Italia 1.045
SG - Singapore 817
CN - Cina 396
BR - Brasile 257
HK - Hong Kong 231
VN - Vietnam 199
NL - Olanda 173
FR - Francia 126
JP - Giappone 72
BD - Bangladesh 64
KR - Corea 52
GB - Regno Unito 51
IN - India 49
MX - Messico 43
CA - Canada 39
AR - Argentina 21
TH - Thailandia 19
DE - Germania 18
TR - Turchia 18
FI - Finlandia 16
IL - Israele 11
PL - Polonia 11
SA - Arabia Saudita 10
ZA - Sudafrica 10
ES - Italia 9
IQ - Iraq 9
UA - Ucraina 9
MA - Marocco 7
CO - Colombia 6
EG - Egitto 6
AT - Austria 5
EC - Ecuador 5
KZ - Kazakistan 5
NP - Nepal 5
PE - Perù 5
TN - Tunisia 5
TW - Taiwan 5
AZ - Azerbaigian 4
ID - Indonesia 4
IE - Irlanda 4
KE - Kenya 4
LB - Libano 4
MT - Malta 4
PK - Pakistan 4
PT - Portogallo 4
PY - Paraguay 4
RU - Federazione Russa 4
SE - Svezia 4
VE - Venezuela 4
BE - Belgio 3
BO - Bolivia 3
BS - Bahamas 3
CH - Svizzera 3
JM - Giamaica 3
JO - Giordania 3
PH - Filippine 3
QA - Qatar 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BG - Bulgaria 2
BY - Bielorussia 2
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MK - Macedonia 2
PA - Panama 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
GA - Gabon 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
LK - Sri Lanka 1
LT - Lituania 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
RW - Ruanda 1
SO - Somalia 1
YT - Mayotte 1
Totale 5.322
Salva come PNG Salva come JPEG
Città #
Santa Clara 565
Singapore 474
Hong Kong 225
San Jose 200
Hefei 143
Beijing 105
Ashburn 93
Rome 92
Lauterbourg 90
Ho Chi Minh City 83
Milan 63
Los Angeles 62
Tokyo 62
Seoul 52
Hanoi 41
Florence 39
Naples 37
New York 36
Bari 28
Orem 23
São Paulo 21
Council Bluffs 19
Dallas 18
Bangkok 17
Quattro Castella 17
Bologna 14
West Jordan 14
Boardman 12
Montreal 12
Palermo 12
Amsterdam 11
Buffalo 11
London 11
Manchester 11
Chennai 10
Genoa 10
Turin 9
Minamishinagawa 8
Padua 8
Paris 8
Turku 8
Brooklyn 7
Dhaka 7
Haiphong 7
Houston 7
Toronto 7
Washington 7
Belo Horizonte 6
Bengaluru 6
Cagliari 6
Catania 6
Da Nang 6
Frankfurt am Main 6
Helsinki 6
Johannesburg 6
Manaus 6
Munich 6
New Delhi 6
Trieste 6
Baghdad 5
Guangzhou 5
Shanghai 5
Alessandria 4
Baku 4
Biên Hòa 4
Brasília 4
Chicago 4
Dublin 4
Gricignano di Aversa 4
Juiz de Fora 4
Madrid 4
Modena 4
Mumbai 4
Pescara 4
Piscataway 4
Ribeirão Preto 4
Rio de Janeiro 4
San Francisco 4
Stockholm 4
São José dos Campos 4
Thái Bình 4
Tijuana 4
Torreón 4
Verona 4
Vienna 4
Warsaw 4
Almaty 3
Amman 3
Beirut 3
Benito Juarez 3
Blumenau 3
Brescia 3
Cairo 3
Campinas 3
Catanzaro 3
Caxias do Sul 3
Chapecó 3
Charlotte 3
Corciano 3
Coyoacán 3
Totale 3.041
Salva come PNG Salva come JPEG
Nome #
Tipizzazione HLA-A, -B, -C, -DRB1, -DRB3/4/5, -DQA1, -DQB1, -DPA1, -DPB1 del potenziale donatore d'organo mediante tecnica di RT PCR-SSP 589
"Virtual" crossmatch quale strumento di selezione dei potenziali riceventi nel trapianto di rene. 325
Diagnosi e trattamento del rigetto umorale nel paziente cardiotrapiantato: esperienza di un singolo centro 176
Allocation Policy PNI-analisi accessibilità al programma trapianto di rene e valutazione del graft outcome in pazienti iperimmuni della Regione Lazio 156
FLOW CYTOMETRY CROSSMATCH: FCXM VS. FLOWDSA-XM 123
The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center 110
Virtual Crossmatch in Kidney Transplantation 102
CLINICAL RELEVANCE OF PREFORMED "ACCEPTABLE" DONOR SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANTATION. 100
FEASIBLE EXTENDED HLA TYPING OF DECEASED DONORS IN SOLID ORGAN TRANSPLANTATION 93
C1Q-FIXING HLA ANTIBODIES AND KIDNEY GRAFT OUTCOME 86
B-sides serological markers of immunogeneticy in kidney transplanted patients: report from 2012/2013 flu vaccination experience 79
Renal allograft immune response is influenced by patient and donor cytokine genotypes. 77
HLA ANTIBODY TESTING BY CLASSICAL AND MODIFIED LUMINEX-SINGLE ANTIGEN BEADS ASSAYS. 68
DE NOVO PRODUCTION OF C1Q-FIXING DONOR-SPECIFIC ANTIBODIES IS ASSOCIATED WITH KIDNEY ALLOGRAFT LOSS 58
ANGIOTENSIN II TYPE-1 RECEPTOR ANTIBODIES AND KIDNEY GRAFT OUTCOME 58
VIRTUAL CROSSMATCH E DEFINIZIONE DI "ANTIGENI PROIBITI" MEDIANTE TECNICA DELLE SINGLE ANTIGEN BEADS. 57
Post-transplant development of C1q-positive HLA antibodies and kidney graft survival. 57
Presensibilizzazione HLA nei pazienti in lista per trapianto di rene presso CRT-Lazio: incidenza, specificità e "forza" degli anticorpi evidenziati 52
VIRTUAL CROSSMATCH AND CLINICAL RELEVANCE OF HLA ANTIBODIES DETECTED BY LUMINEX-SINGLE ANTIGEN BEADS. 51
Anticorpi anti-recettori dell'angiotensina di tipo II e dell'endothelina-1 di tipo A nel trapianto di rene pediatrico 51
Angiotensin II Type I Receptor Antibodies and Kidney Graft Outcome 50
Anticorpi anti-HLA e anti-MICA donatore-specifici e andamento clinico del trapianto di rene. 50
RARE HLA ALLELES AND IMPACT ON HLA-MATCHING IN KIDNEY TRANSPLANTATION. 50
INTERPRETING THE RESULTS OF LUMINEX-SINGLE ANTIGEN BEADS ASSAY 50
HLA Antibodies Detected by Luminex-Single Antigen Beads and Virtual Crossmatch in Renal Transplantation 50
Uncommon HLA Alleles/Haplotypes and HLA-Matching in Renal Transplantation 49
HLA Antibobies Detected by Luminex-Single Antigen Beads and Virtual Crossmatch in Renal Transplantation 49
NON-HLA ANTIBODIES AND KIDNEY TRANSPLANTATION: RELEVANCE OF AT1R ANTIBODIES ON GRAFT OUTCOME 49
PRE-TRANSPLANT HLA ANTIBODY SCREENING BY SOLID PHASE ASSAYS: INCIDENCE OF ANTI-HLA IGM ANTIBODIES IN KIDNEY TRANSPLANT CANDIDATES 49
DE NOVO DONOR SPECIFIC ANTIBODIES (DNDSA) AND KIDNEY TRANSPLANTATION (KTX) OUTCOME: A SINGLE CENTER EXPERIENCE 48
Valutazione della capacità degli anticorpi anti-HLA di attivare il complemento 47
C1Q-FIXING HLA ANTIBODIES AND KIDNEY TRANSPLANTATION 47
SUCCESSFUL KIDNEY TRANSPLANTATION IN HIGHLY SENSITIZED PATIENTS WITH ONCE DAILY TACROLIMUS BASED IMMUNOSUPPRESSION 47
PREFORMED "ACCEPTABLE" DONOR SPECIFIC ANTIBODIES AND GRAFT OUTCOME IN KIDNEY TRANSPLANTATION 45
Clinical Relevance of C1q-Fixing HLA Antibodies in Kidney Transplantation 44
HLA-DPA1 and -DPB1 Antibodies in Kidney Transplantation 44
Acute kidney transplant rejection mediated by angiotensin II type 1 receptor antibodies in a pediatric hyperimmune patient 43
Post-transplant donor-specific antibody production and graft outcome in kidney transplantation: results of 16-year monitoring by flow cytometry. 43
UNCOMMON HLA ASSOCIATION IN RENAL TRANSPLANT RECIPIENTS 43
Anticorpi donatore-specifici DSA: prevenirli è meglio che curarli 41
Enhanced characterization of pre-sensitization status in kidney transplant candidates using sensitive techniques. 41
Enhanced detection and characterization of HLA-sensitization in renal transplant recipients 41
CALCINEURIN INHIBITOR-FREE IMMUNOSUPPRESSION IN DUAL KIDNEY TRANSPLANTATION FROM MARGINAL DONORS - SINGLE CENTRE EXPERIENCE 40
Specificità HLA classe I e classe II degli anticorpi prodotti dopo trapianto e rigetto cronico nel trapianto di rene. 40
Impact of donor-specific anti-HLA antibodies and donor KIR characteristics in haploidentical HSCT for beta-Thalassemia 40
Rilevanza clinica degli anticorpi anti-HLA prodotti dopo trapianto di rene 40
Anti HLA-C presensitization in kidney Transplant recipients. Preliminary data on the epitope specificity of HLA-C antibodies. 39
Anti-HLA antibodies after soluble antigens absorption, genomic HLA compatibility and acute rejection in kidney transplantation 39
Virtual crossmatch in the Luminex-Single Antigen beads era 39
Differenze nel Locus HLA-DPB1 e risposta umorale nel trapianto di rene da donatore cadavere. 39
Improving screening strategies for HLA-specific antibody detection in renal transplant recipients 39
Incidence and specificity of anti HLA-DP antibodies in kidney retransplants patients 38
Flow Cytometry Crossmatch:A Sensitive Technique for assessment of acute rejection in renal transplantation 38
HLA-DPA1 and -DPB1 antibodies in kidney transplant candidates 37
The role of beta-pleated sheet DRB1 differences in acute rejection after cadaveric kidney transplantation. 37
RARE HLA ALLELES IN RENAL TRANSPLANT CANDIDATES 37
Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation post transplant analysis using flow cytometric techniques. 36
Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow citometric techniques. 36
Analysis of cytokine genotypes in cadaveric renal transplantation 36
EPITOPE SPECIFICITY OF HLA DQA1 AND DQB1 ANTIBODIES DETECTED IN SERA FROM RENAL TRANSPLANT RECIPIENTS. 36
Allosensibilizzazione in candidati al trapianto di rene: caratterizzazione mediante tecniche citofluorimetriche. 35
HLA antibodies in kidney transplantation 34
HLA class II genotyping, donor-specific antibodies and early episodes of acute rejection in kidney transplant. 34
"Intra-Broad" and "Intra-Allele" HLA alloantibodies 34
MICA antibodies in kidney transplanted patients. 33
HLA Class II reactive sera from kidney allograft recipients: detection of antibodies specific for epitops of DQ and DP alpha/beta chains 33
Studio immunologico nel candidato a trapianto di rene e nel follow-up post trapianto 32
RARA ASSOCIAZIONE HLA DR-DQ 31
HLA-DQ AND -DP ALPHA/BETA CHAIN ANTIBODIES IN RENAL TRANSPLANTATION 31
Relevance of post-transplant HLA class I and class II antibodies on renal graft outcome. 31
Relevance of post-transplant HLA class I and classII antibodies on renal graft outcome 31
Graft failure due to Hemolytic uremic sindrome recurrence. 29
Clinical significance of de novo production of HLA donor-specific antibodies in kidney transplantation 29
HLA expression on tumor cells and serum levels of soluble IL-2 receptor in colorectal cancer 29
Antibody production against mismatched HLA class I antigens of a kidney graft in mainly due to the recognition of a single public epitope. 29
Kidney transplant monitoring by anti donor specific antibodies 29
Strenght/Specificity of de novo HLA donor-specific antibodies in Kidney Transplantation 29
Comparison between HLA-DR serological typing and oligotyping in kidney transplant: a single centre experience 29
HLA specificity of post tranplant alloantibodies and kidney graft outcome. 28
Chronic rejection and humoral alloreactivity in kidney transplantation. 28
Epitope specificity of HLA DQA1 and DQB1 antibodies detected in sera from renal transplant recipients 28
Incidence and epitope specificity of HLA DQA1 and DQB1 antibodies in renal transplant recipients. 27
Antidonor-HLA antibodies and soluble HLA antigens after kidney transplant. 27
Post-transplant HLA and MICA antibodies and kidney graft outcome 27
HLA and MICA antibodies and graft outcome in 448 kidney transplanted patients. 27
Immunologic monitoring in kidney transplantation 26
Influence of patient and donor cytokine genotypes on renal allograft immune responce. 26
Immunosuppression and humoral responce in kidney transplantation 26
Enhanced detection and characterization of HLA-sensitization in renal transplant recipients 26
Searching into MICA Antibodies. 26
Posttransplant donor-specific antibody characterization and kidney graft survival 26
Sviluppo di anticorpi anti-HLA donatori-specifici e rigetto cronico nel trapianto di rene. 26
Humoral alloreactivity after kidney transplantation an important risk factor for chronic allograft dysfunction. 25
Humoral alloreactivity against HLA Class II graft molecules (DR, DQ, DP and Public-Antigens) in kidney transplantation: correlation with transplant outcome. 25
Improving screening strategies for HLA-specific antibody detection in renal transplant recipients. 25
HLA class I sensitization from a kidney graft is mainly due to the recognition of a single public epitope 24
Post-transplant HLA Class I and II Donor-specific antibodies: the main risk factor for chronic allograft dysfunction in kidney transplantation. 23
Post-transplant HLA antibody specificity, therapy protocols and kidney graft outcome. 23
Suppression of antidonor antibody production by mycophenolato mofetil in renal transplanted patients. 23
Enhanced characterization of pre-sensitization status in kidney transplant candidates using sensitive techniques. 22
Totale 5.300
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.957
article - articoli 8.570
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 286
Totale 23.813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024120 0 0 0 0 0 0 0 0 0 74 25 21
2024/20251.934 10 24 129 80 506 133 81 74 80 65 404 348
2025/20263.350 153 267 244 419 474 191 477 186 290 301 287 61
Totale 5.404